☆ 4.6 Letter

Differential Response to Interleukin-1 Blockade With Anakinra on Cardiorespiratory Fitness in Patients With Heart Failure With Preserved Ejection Fraction Stratified According to Left Ventricular Ejection Fraction

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

A reclassification of heart failure based on recognition of heart failure with normal to supernormal ejection fraction, a clinically common form of cardiac contracture, with distinctive pathophysiological and therapeutic features

Milton Packer

EUROPEAN JOURNAL OF HEART FAILURE (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction

Javed Butler et al.

Summary: The impact of empagliflozin on heart failure outcomes was consistent and clinically meaningful in patients with ejection fractions <25% to <65%, but attenuated in those with ejection fraction >= 65%.

EUROPEAN HEART JOURNAL (2022)

添加到收藏夹

Letter Cardiac & Cardiovascular Systems

Interactions between left ventricular ejection fraction, sex and effect of neurohumoral modulators in heart failure

Pooja Dewan et al.

EUROPEAN JOURNAL OF HEART FAILURE (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction: Results From DHART2

Benjamin W. Van Tassell et al.

CIRCULATION-HEART FAILURE (2018)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Effects of Interleukin-1 Blockade With Anakinra on Aerobic Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction (from the D-HART Pilot Study)

Benjamin Wallace Van Tassell et al.

AMERICAN JOURNAL OF CARDIOLOGY (2014)

添加到收藏夹

Differential Response to Interleukin-1 Blockade With Anakinra on Cardiorespiratory Fitness in Patients With Heart Failure With Preserved Ejection Fraction Stratified According to Left Ventricular Ejection Fraction

相关参考文献

A reclassification of heart failure based on recognition of heart failure with normal to supernormal ejection fraction, a clinically common form of cardiac contracture, with distinctive pathophysiological and therapeutic features

Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction

Interactions between left ventricular ejection fraction, sex and effect of neurohumoral modulators in heart failure

IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction: Results From DHART2

Effects of Interleukin-1 Blockade With Anakinra on Aerobic Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction (from the D-HART Pilot Study)

导出引文

分享论文